Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia

Blood

Volumn 99, Issue 6, 2002, Pages 2259-2261

  Casato, Milvia ^a,b,c,d   Mecucci, Cristina ^a,b,c,d   Agnello, Vincent ^a,b,c,d   Fiorilli, Massimo ^a,b,c,d   Knight, Glenn B ^a,b,c,d   Matteucci, Caterina ^a,b,c,d   Gao, Lei ^a,b,c,d   Kay, Jonathan ^a,b,c,d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; PROTEIN BCL 2; RHEUMATOID FACTOR;

ADULT; ARTICLE; CASE REPORT; CRYOGLOBULINEMIA; GENE OVEREXPRESSION; GENE TRANSLOCATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MALE; PARTIAL TRISOMY; PATHOPHYSIOLOGY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; REMISSION; VASCULITIS;

EID: 0037085784     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.6.2259     Document Type: Article

References (22)

1. A role for hepatitis C virus infection in type II cryoglobulinemia
2. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection
3. Essential mixed cryoglobulinemia, type II: A manifestation of a low-grade malignant lymphoma? Clinical morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections
4. Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobutinemia: Clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma
5. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection
6. Comparitive genomic hybridization for molecular cytogenetic analysis of solid tumors
7. Optimization of comparative genomic hybridization using fluorochrome conjugated to dCTP and dUTP nucleotides
8. Novel 5′ exonuclease-based real-time PCR assay for the detection of t(14;18)(q32;q21) in patients with follicular lymphoma
9. Human rheumatoid factor cross-idiotypes. IV. Studies on WA XId-positive IgM without rheumatoid factor activity provide evidence that the WA XId is not unique to rheumatoid factors and is distinct from the 17.109 and G6 XIds
10. Bcl-2 over-expression in the absence of t(14;18)(q32;q21) chromosomal translocation in hybridomas and lymphocytes expressing monoclonal IgM from HCV patients
11. Genetic abnormalities in marginal zone B-cell lymphoma
12. Distribution of the cytogenetic abnormality +i(3)(q10) in persistent polyclonal B-cell lymphocytosis: A FICTION study in three cases
13. Distinct chromosome 3 abnormalities in persistent polyclonal B-cell lymphocytosis
14. Non-MALT marginal zone B-cell lymphomas: A description of clinical presentation and outcome in 124 patients
15. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia
16. WA monoclonal rheumatic factors and non-Hodgkin's lymphoma
17. Biologic and clinical significance of cryoglobulins. A report of 86 cases
18. Mixed cryoglobulinemia: An update of recent clinical experience
19. Lkv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas
20. Gastric MALT lymphoma: From concept to cure
21. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia
22. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia